Iovance Biotherapeutics
IOVA
#3883
Rank
$3.19 B
Marketcap
$6.90
Share price
-5.61%
Change (1 day)
205.31%
Change (1 year)

EPS for Iovance Biotherapeutics (IOVA)

EPS in 2026 (TTM): -$0.53

According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is -$0.53. In 2025 the company made an earnings per share (EPS) of -$1.12 an increase over its 2024 EPS that were of -$1.30.

EPS history for Iovance Biotherapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.53-52.68%
2025-$1.12-13.85%
2024-$1.30
2022-$2.4811.71%
2021-$2.22
2019-$1.5823.44%
2018-$1.28-9.22%
2017-$1.41-20.34%
2016-$1.77176.56%
2015-$0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-$0.06000-88.68% Bahamas
NRC Health
NRC
$0.29-154.72%๐Ÿ‡บ๐Ÿ‡ธ USA